Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/154180
Full metadata record
DC FieldValueLanguage
dc.creatorRama, TA
dc.creatorHenriques, AF
dc.creatorMatito, A
dc.creatorJara-Acevedo, M
dc.creatorCaldas, C
dc.creatorMayado, A
dc.creatorMuñoz-González, JI
dc.creatorMoreira, A
dc.creatorCavaleiro Rufo, J
dc.creatorGarcía-Montero, A
dc.creatorÓrfão, A
dc.creatorSanchez-Muñoz, L
dc.creatorÁlvarez-Twose, I
dc.date.accessioned2023-11-14T11:29:43Z-
dc.date.available2023-11-14T11:29:43Z-
dc.date.issued2023
dc.identifier.issn2213-2198
dc.identifier.urihttps://hdl.handle.net/10216/154180-
dc.description.abstractBackground Mastocytosis encompasses a heterogeneous group of diseases characterized by tissue accumulation of clonal mast cells, which frequently includes bone involvement. Several cytokines have been shown to play a role in the pathogenesis of bone mass loss in systemic mastocytosis (SM), but their role in SM-associated osteosclerosis remains unknown. Objective To investigate the potential association between cytokine and bone remodeling markers with bone disease in SM, aiming at identifying biomarker profiles associated with bone loss and/or osteosclerosis. Methods A total of 120 adult patients with SM, divided into 3 age and sex-matched groups according to their bone status were studied: (1) healthy bone (n = 46), (2) significant bone loss (n = 47), and (3) diffuse bone sclerosis (n = 27). Plasma levels of cytokines and serum baseline tryptase and bone turnover marker levels were measured at diagnosis. Results Bone loss was associated with significantly higher levels of serum baseline tryptase (P = .01), IFN-γ (P = .05), IL-1β (P = .05), and IL-6 (P = .05) versus those found in patients with healthy bone. In contrast, patients with diffuse bone sclerosis showed significantly higher levels of serum baseline tryptase (P < .001), C-terminal telopeptide (P < .001), amino-terminal propeptide of type I procollagen (P < .001), osteocalcin (P < .001), bone alkaline phosphatase (P < .001), osteopontin (P < .01), and the C-C Motif Chemokine Ligand 5/RANTES chemokine (P = .01), together with lower IFN-γ (P = .03) and RANK-ligand (P = .04) plasma levels versus healthy bone cases. Conclusions SM with bone mass loss is associated with a proinflammatory cytokine profile in plasma, whereas diffuse bone sclerosis shows increased serum/plasma levels of biomarkers related to bone formation and turnover, in association with an immunosuppressive cytokine secretion profile.
dc.description.sponsorshipThis study was supported by grants from the Instituto de Salud Carlos III (ISCIII, Spain) (PI19/01166, CIBERONC: CB16/12/00400) and Fondo Europeo de Desarrollo Regional (FEDER) (EQC2019-005419-P), within the Subprograma Estatal de Infraestructuras de Investigación y Equipamiento Científico Técnico de 2019 del Ministerio de Ciencia, Innovación y Universidades, Fundación Española de Mastocitosis (FEM, Madrid, Spain ref.: FEM2019-MAGPIX and FEM2021-SAM); Asociación Española de Mastocitosis y Enfermedades Relacionadas (AEDM-CTMC-2019). We also thank the Biobank at the Hospital Virgen de la Salud (BioB-HVS) No. B.0000520, Toledo, Spain. TAR was supported by the 2019 European Academy of Allergy and Clinical Immunology Research Fellowship award. We thank our patients for their willingness to participate in this study.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofJ Allergy Clin Immunol Pract. 2023 May;11(5):1536-1547. doi: 10.1016/j.jaip.2023.02.007. Epub 2023 Feb 18.
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleBone and Cytokine Markers Associated With Bone Disease in Systemic Mastocytosis
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto
dc.identifier.doi10.1016/j.jaip.2023.02.007
dc.relation.publisherversionhttps://jaci-inpractice.org/article/S2213-2198(23)00186-1/fulltext
Appears in Collections:ISPUP - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
rama-jacig2023.pdf1.27 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons